Marijuana's new drug classification could unlock long-delayed medical research
The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.
More from All Things Considered
-
Tariffs, immigration crackdown, funding cuts: BU professor warns of ‘Trump Trifecta’
Mark Williams says the effects on Massachusetts from President Trump's federal policy changes amounts to an “economic attack.” -
Why Mass. needs an ‘economic war room’ to protect itself from Trump policies
With billions at stake, BU’s Mark Williams outlines how state officials can soften the blow of federal policies targeting research funding, trade, and immigration. -
Pressley warns Trump-backed budget bill would hurt Mass. residents
The congresswoman says residents in her district and across the state who rely on MassHealth and SNAP could be at risk. -
Women make up just 16% of the robotics field. MassRobotics wants to change that.
The Jumpstart Fellowship Program is encouraging young girls of all backgrounds to enter the field and grow confident in their abilities. -
In a Pentucket school cafeteria, you can go to a one-night-only jazz club
David Schumacher, who has led Café Jazz for 25 years, brought the annual tradition with him from his own high school jazz band days. -
MA legislators promise greater transparency. This group of Cambridge voters is holding them to it.
Cambridge Committee for Transparency and Accountability is pushing for a legislative audit and other reforms. -
Why are more young people having heart attacks?
While heart attack rates are declining in older populations, they’re rising among younger adults — those in their 30s, and even their 20s.
